Long Covid Solutions Congress 2022
Watch the full replay here, packed full of valuable research and therapy options for long Covid sufferers.
Professor Resia Pretorius – South Africa
She is a Physiologist, distinguished professor and Chair in the Department of Physiological Sciences, Stellenbosch University, South Africa. She studies cells and proteins in the coagulation system, including platelets, erythrocytes and the coagulation plasma protein, fibrinogen. She also studies inflammatory biomarkers, including those that have a viral and bacterial origin, that might impact on the coagulation system. Prof Pretorius has published/in press nearly 300 papers, and has delivered various keynote and plenary lectures at international conferences, and is a regular reviewer for scientific journals. Together with Stellenbosch University, she has filed various patents, including treatment methods and biosensors for early detection of disease risk. Recently, she filed a provisional patent for a method for the diagnosis of Long COVID. In May 2021, Prof Pretorius launched the South African Long COVID registry and was on the WHO Long COVID panel in 2021.
Dr Bruce Patterson – USA
He received his undergraduate training in molecular biology from the University of Michigan in Ann Arbor. He then went on to Northwestern University Medical School for training in medicine. During the early stages of the AIDS epidemic, Dr. Patterson began investigating cellular reservoirs of HIV-1 using molecular and in situ technology patented in his laboratory. He went on to a residency in Pathology focusing on viral pathogenesis. While in his residency, Dr. Patterson determined that enough HIV virus was present in infected individuals to account for the massive destruction of the immune system. This paradigm altering work was published in Science in 1993. Dr. Patterson later was named Chief Resident of Pathology at Northwestern Memorial Hospital. He has authored over 100 manuscripts and book chapters and continues his medical work at IncellDx. Dr. Patterson was the Medical Director of Diagnostic Virology at Stanford University Hospitals and Clinics.
Joachim Gerlach – Germany
He is a German entrepreneur and expert in research and development. He has experience in financing and coordinating multiple projects, including sustainable organic agriculture, reforestation and agroforestry projects, restoring micronutrition levels in plants, animals and humans, as well as the development and production of targeted nutraceuticals. Mr Gerlach is the Founder of GREEN INDUSTRY GROUP GmbH (Germany-Costa Rica) and VITALIS FOUNDATION SPAIN (Canary Islands), and Co-founder of VEDICINALS INDIA PVT LTD, a biotech company that recently developed a novel nutraceutical protocol to support patients with acute- and Long-Covid conditions. The resulting product VEDICINALS 9 has successfully completed extensive preclinical and clinical trials.
Dr Tina Peers – United Kingdom
Since qualifying in Medicine at Guys’ Hospital London in 1983, Dr. Tina Peers has developed her skills and knowledge in women’s health, first working as a GP in Surrey, then becoming a Consultant in Contraception and Reproductive Health in 1996, and leading these services in Surrey until 2018. In 2019 Dr. Peers established The Menopause Consultancy, a specialist Menopause & Women’s Health clinic and a centre of excellence to provide evidence-based care for women. Since the outbreak of COVID-19, Dr. Peers has begun treating those suffering from Long Covid, using her expertise in Histamine Intolerance and Mast Cell Activation Syndrome to inform treatment plans.
Dr Abdul Mannan Baig – Pakistan
He is a scientist from Pakistan. He is an active clinical and basic scientist in COVID-19 and Long-COVID. He has contributed towards translational research in COVID-19 from the beginning of the pandemic. His research has contributed to the recognition of loss of smell and taste in COVID-19 that he hinted in March 2020, including the proposal on SARS-CoV-2 virus using the nose to access the brain. Dr Baig was recently commissioned by Nature Reviews Neurology to write for the journal on neurological deficits caused by SARS-CoV-2 in COVID and such findings as are being reported in Long-COVID. He has over 32 papers on COVID-19 and is considered an expert in Long-COVID and neurological research in COVID-19. Dr Baig is the recipient of the national award of distinguished scientist by Pakistan Scientific Society and is the recipient of the most productive researcher at Aga Khan University, Karachi, Pakistan in the years 2017-2020.